October 27, 2024
Now available PAVBLU™
PAVBLU™ (aflibercept-ayyh) injection, for intravitreal use, is a vascular endothelial growth factor (VEGF) inhibitor
indicated for the treatment of patients with:
- Neovascular (Wet) Age-Related Macular Degeneration (AMD)
- Macular Edema Following Retinal Vein Occlusion (RVO)
- Diabetic Macular Edema (DME)
- Diabetic Retinopathy (DR)